|
1
|
Kamangar F, Qiao YL, Schiller JT, Dawsey
SM, Fears T, Sun XD, Abnet CC, Zhao P, Taylor PR and Mark SD: Human
papillomavirus serology and the risk of esophageal and gastric
cancers: Results from a cohort in a high-risk region in China. Int
J Cancer. 119:579–584. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arnold M, Soerjomataram I, Ferlay J and
Forman D: Global incidence of oesophageal cancer by histological
subtype in 2012. Gut. 64:381–387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lagergren J: Oesophageal cancer in 2014:
Advances in curatively intended treatment. Nat Rev Gastroenterol
Hepatol. 12:74–75. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo Y, Chen Z, Zhang L, Zhou F, Shi S,
Feng X, Li B, Meng X, Ma X, Luo M, et al: Distinctive microRNA
profiles relating to patient survival in esophageal squamous cell
carcinoma. Cancer Res. 68:26–33. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fendler A, Jung M, Stephan C, Honey RJ,
Stewart RJ, Pace KT, Erbersdobler A, Samaan S, Jung K and Yousef
GM: miRNAs can predict prostate cancer biochemical relapse and are
involved in tumor progression. Int J Oncol. 39:1183–1192.
2011.PubMed/NCBI
|
|
8
|
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima
S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P
and Stoffel M: A pancreatic islet-specific microRNA regulates
insulin secretion. Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
van de Bunt M, Gaulton KJ, Parts L, Moran
I, Johnson PR, Lindgren CM, Ferrer J, Gloyn AL and McCarthy MI: The
miRNA profile of human pancreatic islets and beta-cells and
relationship to type 2 diabetes pathogenesis. PLoS One.
8:e552722013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan JW, Lin JS and He XX: The emerging
role of miR-375 in cancer. Int J Cancer. 135:1011–1018. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang F, Li Y, Zhou J, Xu J, Peng C, Ye F,
Shen Y, Lu W, Wan X and Xie X: miR-375 is down-regulated in
squamous cervical cancer and inhibits cell migration and invasion
via targeting transcription factor SP1. Am J Pathol. 179:2580–2588.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:2015. View Article : Google Scholar
|
|
14
|
Li D, Li X, Cao W, Qi Y and Yang X:
Antagonism of microRNA-99a promotes cell invasion and
down-regulates E-cadherin expression in pancreatic cancer cells by
regulating mammalian target of rapamycin. Acta Histochem.
116:723–729. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bartels CL and Tsongalis GJ: MicroRNAs:
Novel biomarkers for human cancer. Clin Chem. 55:623–631. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Komatsu S, Ichikawa D, Takeshita H,
Tsujiura M, Morimura R, Nagata H, Kosuga T, Iitaka D, Konishi H,
Shiozaki A, et al: Circulating microRNAs in plasma of patients with
oesophageal squamous cell carcinoma. Br J Cancer. 105:104–111.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan S, Jiang H, Fang S, Yin F, Wang Z, Jia
Y, Sun X, Wu S, Jiang T and Mao A: MicroRNA-340 inhibits esophageal
cancer cell growth and invasion by targeting phosphoserine
aminotransferase 1. Cell Physiol Biochem. 37:375–386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun Y, Yu X and Bai Q: miR-204 inhibits
invasion and epithelial-mesenchymal transition by targeting FOXM1
in esophageal cancer. Int J Clin Exp Pathol. 8:12775–12783.
2015.PubMed/NCBI
|
|
19
|
Komatsu S, Ichikawa D, Takeshita H,
Konishi H, Nagata H, Hirajima S, Kawaguchi T, Arita T, Shiozaki A,
Fujiwara H, et al: Prognostic impact of circulating miR-21 and
miR-375 in plasma of patients with esophageal squamous cell
carcinoma. Expert Opin Biol Ther. 12 Suppl 1:S53–S59. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
He XX, Chang Y, Meng FY, Wang MY, Xie QH,
Tang F, Li PY, Song YH and Lin JS: MicroRNA-375 targets AEG-1 in
hepatocellular carcinoma and suppresses liver cancer cell growth in
vitro and in vivo. Oncogene. 31:3357–3369. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mathé EA, Nguyen GH, Bowman ED, Zhao Y,
Budhu A, Schetter AJ, Braun R, Reimers M, Kumamoto K, Hughes D, et
al: MicroRNA expression in squamous cell carcinoma and
adenocarcinoma of the esophagus: Associations with survival. Clin
Cancer Res. 15:6192–6200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kano M, Seki N, Kikkawa N, Fujimura L,
Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M and
Matsubara H: miR-145, miR-133a and miR-133b: Tumor-suppressive
miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J
Cancer. 127:2804–2814. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky
DJ and Fisher PB: Cloning and characterization of HIV-1-inducible
astrocyte elevated gene-1, AEG-1. Gene. 353:8–15. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brown DM and Ruoslahti E: Metadherin, a
cell surface protein in breast tumors that mediates lung
metastasis. Cancer Cell. 5:365–374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li WF, Ou Q, Dai H and Liu CA:
Lentiviral-mediated short hairpin RNA knockdown of MTDH inhibits
cell growth and induces apoptosis by regulating the PTEN/AKT
pathway in hepatocellular carcinoma. Int J Mol Sci. 16:19419–19432.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang C, Zheng S, Liu Q, Liu T, Lu M, Dai
F, Gao X, Sheyhidin I and Lu X: Metadherin is required for the
proliferation, migration, and invasion of esophageal squamous cell
carcinoma and its meta-analysis. Transl Res. 166:614–626.e2. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Holash J, Maisonpierre PC, Compton D,
Boland P, Alexander CR, Zagzag D, Yancopoulos GD and Wiegand SJ:
Vessel cooption, regression, and growth in tumors mediated by
angiopoietins and VEGF. Science. 284:1994–1998. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Eriksson A, Cao R, Pawliuk R, Berg SM,
Tsang M, Zhou D, Fleet C, Tritsaris K, Dissing S, Leboulch P and
Cao Y: Placenta growth factor-1 antagonizes VEGF-C-induced
angiogenesis and tumor growth by the formation of functionally
inactive PlGF-1/VEGF heterodimers. Cancer Cell. 1:99–108. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu GC, Yu CY, She L, Tan HL, Li G, Ren
SL, Su ZW, Wei M, Huang DH, Tian YQ, et al: Metadherin regulation
of vascular endothelial growth factor expression is dependent upon
the PI3K/Akt pathway in squamous cell carcinoma of the head and
neck. Medicine (Baltimore). 94:e5022015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Emdad L, Lee SG, Su ZZ, Jeon HY, Boukerche
H, Sarkar D and Fisher PB: Astrocyte elevated gene-1 (AEG-1)
functions as an oncogene and regulates angiogenesis. Proc Natl Acad
Sci USA. 106:pp. 21300–21305. 2009; View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fu M, Wang C, Li Z, Sakamaki T and Pestell
RG: Minireview: Cyclin D1: Normal and abnormal functions.
Endocrinology. 145:5439–5447. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li PP, Feng LL, Chen N, Ge XL, Lv X, Lu K,
Ding M, Yuan D and Wang X: Metadherin contributes to the
pathogenesis of chronic lymphocytic leukemia partially through
Wnt/β-catenin pathway. Med Oncol. 32:4792015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, Del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li X, Kong X, Huo Q, Guo H, Yan S, Yuan C,
Moran MS, Shao C and Yang Q: Metadherin enhances the invasiveness
of breast cancer cells by inducing epithelial to mesenchymal
transition. Cancer Sci. 102:1151–1157. 2011. View Article : Google Scholar : PubMed/NCBI
|
